Engineered for global healthcare brands, Amazon leaders, and clinical supplement companies. We deliver high-absorption Ubiquinone & Ubiquinol softgel formulations with total crystal-precipitation resistance, dark-shell light protection, and a disciplined 90-day execution framework.
Rotary die softgel encapsulation with automated fill weight control
HPLC active assay & stability guarantee included with every CoA
30 years of global pharmaceutical & dietary CDMO heritage
Global procurement executives, pharmaceutical buyers, and brand owners often ask search engines and AI engines: “How do contract manufacturers resolve CoQ10 crystal precipitation, active degradation, and softgel thermal softening?” Here is the comprehensive engineering answer from PAG Pharmatech America.
Coenzyme Q10 (Ubidecarenone) is a crystalline powder with a melting point of approximately 48°C (118.4°F), high lipophilicity (log P > 10), and extremely low aqueous solubility. When formulated into standard dry capsules or crude oil suspensions, less than 1% to 3% of the active compound is absorbed across the intestinal epithelium due to large hydrophobic crystal aggregates.
At PAG Pharmatech America, our CDMO laboratory resolves this physical barrier by utilizing advanced thermal dissolution, lipid-based surfactant matrix technology, and self-emulsifying drug delivery systems (SEDDS). By micro-dispersing CoQ10 below the 100-nanometer threshold within an oil-lecithin vehicle, we prevent post-encapsulation recrystallization while increasing lymphatic transport and systemic Cmax values by up to 300% compared to dry powder formats.
We heat lipid carriers to controlled temperatures within nitrogen-flushed jacketed tanks, fully dissolving crystalline raw CoQ10 into Medium-Chain Triglyceride (MCT) oil, Extra Virgin Olive Oil, or Omega-3 EPA/DHA oil bases without thermal active degradation.
Prevent Crystal RecrystallizationFor oxidized Ubiquinone and reduced Ubiquinol formulas alike, our mixing vessel, transfer piping, and softgel wedge fill lines operate under positive nitrogen gas blankets to eliminate dissolved oxygen and maintain 100% active stability.
Zero Oxygen ExposureCoQ10 degrades under UV wavelength exposure. We manufacture light-blocking softgel shells using caramel, annatto, or riboflavin opacifiers that shield the internal fill solution, maintaining HPLC potency assays across 24-month stability windows.
UV Light Degradation ProtectionWhether your brand targets cardiovascular health, mitochondrial energy, cellular anti-aging, or prenatal fertility, PAG Pharmatech provides customized active dosages, carrier oil selection, and plant-based or gelatin shell options.
Standard oxidized CoQ10 formulated with organic sunflower lecithin, D-alpha tocopherol (Vitamin E), and MCT oil. Available in popular market strengths: 50mg, 100mg, 200mg, 400mg, and 600mg per capsule in Oval or Oblong softgel dies.
High-Volume Commercial BaseBio-identical active form of CoQ10 engineered for aging populations and clinical-grade formulations. Processed under absolute nitrogen isolation to prevent oxidation back into Ubiquinone, maintaining crystal-free liquid stability.
Superior BioavailabilityDual-action cardiovascular and anti-inflammatory softgels combining 100mg CoQ10 with molecularly distilled concentrated Fish Oil (EE or rTG form delivering 300mg EPA / 200mg DHA per softgel) for enhanced lipophilic delivery.
Synergistic Active MatrixAdvanced neuro-energy formulations combining Coenzyme Q10 with Pyrroloquinoline Quinone (PQQ), Alpha-Lipoic Acid (ALA), Trans-Resveratrol, or Acetyl-L-Carnitine for synergistic cellular ATP production and cognitive focus.
Anti-Aging & Brain EnergyNon-GMO modified tapioca starch and carrageenan-free plant softgel shell solutions for 100% vegan brands. Thermal-resistant up to 50°C, preventing sticky softgel clump formation in tropical shipping environments or Amazon FBA inventory.
Clean Label Vegan AlternativeComplete turnkey bottling, amber glass or PET container packaging, child-resistant caps, induction foil heat seals, blister packing, and compliant Supplement Facts panel layout designed for rapid retail onboarding.
Turnkey Finished ProductThe dietary supplement market is experiencing a structural pivot. Sourcing directors and brand managers must align their CoQ10 product roadmaps with emerging consumer demands and regulatory standards through 2030.
While bovine and porcine gelatin softgels remain cost-effective standard options, global buyer queries for non-animal vegetarian softgels (Tapioca Starch and Pectin bases) have grown over 45% year-over-year. Tapioca softgels eliminate cross-linking issues and offer higher heat tolerance during summer logistics.
Consumers are demanding lower active doses with higher clinical efficacy. Self-Emulsifying Drug Delivery Systems (SEDDS) and SMEDDS (micro-emulsifying) are replacing simple oil suspensions. These systems spontaneously form fine oil-in-water micro-emulsions upon contact with gastrointestinal fluids.
Standalone CoQ10 is giving way to complex anti-aging mitochondrial stacks. Sourcing requests now frequently integrate CoQ10 with NAD+ precursors (NMN, NR), Spermidine, Pyrroloquinoline Quinone (PQQ), and Tocotrienols to command premium retail price points.
Marketplaces like Amazon now require mandatory ISO 17025 accredited CoAs verifying full active strength (no under-dosing) and strict compliance with heavy metal thresholds (California Prop 65). Transparent CDMO documentation is now a prerequisite for listing approval.
Softgel contract manufacturing requires rigorous process validation. PAG Pharmatech compresses formulation, thermal blending, rotary die encapsulation, tumble drying, and analytical QA release into a transparent, step-by-step milestone schedule.
Our R&D chemists evaluate active potency, solubilization vehicle (MCT, Sunflower Lecithin, Vitamin E), and run temperature-controlled mixing tests to establish crystal-free suspension stability.
We prepare the gelatin/tapioca ribbon matrix, select softgel die shapes (e.g., 7.5 Oval, 10 Oblong), and conduct a nitrogen-purged pilot production run to calibrate fill-weight variation within ±1.5%.
Commercial encapsulation occurs in our Springville, Utah facility. Softgels pass through continuous tumble dryers and environmental drying tunnels with controlled humidity (<20% RH) to achieve optimal shell hardness.
Third-party ISO-accredited lab assays confirm HPLC active CoQ10 potency, seal strength, heavy metals, and microbiology. Finished bottles or blisters are labeled and prepared for direct shipment to 3PL warehouses.
Softgel manufacturing is a capital-intensive pharmaceutical science. Unlike brokers or virtual suppliers, PAG Pharmatech owns and operates cGMP manufacturing suites in Springville, Utah, engineered specifically for lipophilic active delivery.
Utah cGMP Softgel Cleanrooms 
Rotary Die Encapsulation 
Climate-Controlled Warehousing 
In-House QC & HPLC Laboratory 
High-Precision Gel Ribbon Control Years of pharmaceutical & dietary CDMO heritage supporting US and global supplement brands.
Contact UsEliminate regional tariff risks, supply chain single-point failures, and transit bottlenecks. PAG’s integrated global manufacturing system allows you to formulate once and scale worldwide.
FDA-registered, 21 CFR Part 111 & 117 cGMP facility with SQF Edition 9 accreditation. Built for rapid North American distribution, Amazon FBA readiness, and low-MOQ brand launches.
Primary US Softgel FacilityEuropean CDMO hub operating under strict EU-GMP regulations. Ideal for brands distributing across the European Union, UK, and Middle East with full EFSA compliance documentation.
European Market ExpansionProviding strategic raw material supply leverage, competitive ingredient procurement, and ultra-high-volume softgel production capabilities backed by 30 years of manufacturing depth.
Global Material LeverageDetailed answers to the technical, regulatory, and logistics questions most frequently asked by procurement directors during CDMO qualification.
Our minimum order quantity for standard custom CoQ10 softgel formulations starts at 5,000 finished bottles (e.g., 60-count bottles = 300,000 softgels). For specialized softgel formulations requiring custom tooling dies, non-GMO plant-based tapioca shells, or complex self-emulsifying micro-matrices (SEDDS), MOQs range between 300,000 and 1,000,000 softgels depending on active raw material minimum purchase requirements.
CoQ10 naturally crystallizes at temperatures below 48°C, leading to poor intestinal dissolution and uneven fill weights. PAG Pharmatech solves crystal precipitation by combining thermal dissolution blending with lipid surfactants such as Non-GMO Sunflower Lecithin, Medium-Chain Triglyceride (MCT) oil, and natural D-Alpha Tocopherol. This maintains CoQ10 in a solubilized or micro-suspended liquid state throughout the shelf life of the softgel.
Ubiquinone is the conventional, oxidized form of CoQ10. It is chemically robust and easily processed under standard cGMP softgel conditions. Ubiquinol is the electron-rich, reduced active form, which is highly prone to oxidation upon exposure to ambient air or light. PAG manufactures Ubiquinol softgels under an inert nitrogen gas blanket (<0.5% O2 headspace) and utilizes light-blocking opaque softgel shells to guarantee that Ubiquinol does not convert back to Ubiquinone prior to consumer ingestion.
Yes. In addition to traditional bovine and porcine pharmaceutical-grade gelatin shells, we operate dedicated plant-based softgel lines utilizing Non-GMO Modified Tapioca Starch and Seaweed Extract (Carrageenan-free options available). Tapioca softgels offer enhanced thermal stability (resisting leakers and clumping up to 50°C), making them ideal for global shipping and eco-conscious vegan supplement brands.
CoEnzyme Q10 is photolabile and degrades when exposed to ultraviolet and visible light rays. During manufacturing, we add natural opacifying agents to the gelatin ribbon—such as Caramel color, Annatto, Riboflavin, or Titanium Dioxide alternatives—creating an opaque softgel shell that completely blocks light penetration. We also recommend packaging finished products in amber PET, amber glass, or opaque HDPE containers.
Every CoQ10 softgel batch is released with a comprehensive Certificate of Analysis (CoA) issued by an ISO/IEC 17025 accredited laboratory. TheCoA covers: (1) Active HPLC Potency Assay (verifying exact mg target of CoQ10 per softgel), (2) Microencapsulation seal integrity and rupture time, (3) Microbial testing (Total Aerobic Plate Count, Yeast & Mold, E. coli, Salmonella, Staph), (4) Heavy Metal Analysis via ICP-MS (Lead, Cadmium, Arsenic, Mercury adhering to USP and Prop 65 limits), and (5) Disintegration and Dissolution testing according to USP monograph standards.
Yes. Our primary manufacturing facility in Springville, Utah is FDA-registered and operates in strict compliance with 21 CFR Part 111 (Dietary Supplement cGMP) and 21 CFR Part 117 (Preventive Controls for Human Food). We hold third-party SQF Edition 9 Certification (audited by SGS), Utah Department of Agriculture cGMP certification, as well as Halal, Kosher, and USDA Organic handling capabilities. FDA registration confirms facility compliance and does not constitute FDA endorsement of specific end-user products.
Amazon requires dietary supplement sellers to submit ISO 17025 accredited CoAs matching bottle lot numbers, proof of FDA facility registration, and strict adherence to label accuracy guidelines. PAG structures all batch production records and testing packages to satisfy Amazon’s Seller Central compliance portal requirements, ensuring seamless product approval and uninterrupted inventory flow.
Partner with an FDA-registered US CDMO that delivers bioavailability innovation, robust crystal stability, and 90-day market speed. Contact our technical formulation team today.
FDA registration does not constitute FDA approval or endorsement of any finished product. Certifications are held by our FDA-registered manufacturing operations in Utah; certificate copies are shared under NDA during formal supplier qualification.
